Alice S. Carter , Duncan Steele , Jacob John , Senjuti Saha , Matthew B. Laurens , Anna A. Minta , Litiana Volavola , Ismoedijanto Moedjito , Kongxay Phounphenghack , Diana Mahat , Soe Lwin Nyein , Abhiyan Gautam , Maria Fe Viviane S. Sespeñe , Teuila Pati , Nguyen Thi Thu Huong , Nivedita Gupta , Leyanna Susan George , Madhumathi Jayaprakasam , Anuradha Gupta , Denise O. Garrett
{"title":"Advancing typhoid conjugate vaccine implementation in Asia: Regional policy priorities","authors":"Alice S. Carter , Duncan Steele , Jacob John , Senjuti Saha , Matthew B. Laurens , Anna A. Minta , Litiana Volavola , Ismoedijanto Moedjito , Kongxay Phounphenghack , Diana Mahat , Soe Lwin Nyein , Abhiyan Gautam , Maria Fe Viviane S. Sespeñe , Teuila Pati , Nguyen Thi Thu Huong , Nivedita Gupta , Leyanna Susan George , Madhumathi Jayaprakasam , Anuradha Gupta , Denise O. Garrett","doi":"10.1016/j.vaccine.2025.127848","DOIUrl":null,"url":null,"abstract":"<div><div>Typhoid fever, a type of enteric fever transmitted through consumption of food or water contaminated with <em>Salmonella enterica</em> subspecies Typhi, continues to cause illness in Asia. Since the World Health Organization recommended use of typhoid conjugate vaccines in 2018, several countries have introduced or begun the decision-making process to use the vaccine in campaigns or by introduction into the routine immunization schedule. This paper describes the disease burden and vaccine implementation policy setting in the region, based on presentations and discussions at the second Asia Regional Meeting on Typhoid & TCV. Moving forward, typhoid control efforts must prioritize 1) working across health and finance ministries to finance vaccination programs, 2) strengthening surveillance to better understand disease burden, drug resistance trends, and vaccine impact, 3) developing improved diagnostic tests, 4) stewarding antimicrobial use to slow the spread of drug resistance, and 5) evaluating the durability of TCV protection.</div></div>","PeriodicalId":23491,"journal":{"name":"Vaccine","volume":"66 ","pages":"Article 127848"},"PeriodicalIF":4.5000,"publicationDate":"2025-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0264410X25011454","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Typhoid fever, a type of enteric fever transmitted through consumption of food or water contaminated with Salmonella enterica subspecies Typhi, continues to cause illness in Asia. Since the World Health Organization recommended use of typhoid conjugate vaccines in 2018, several countries have introduced or begun the decision-making process to use the vaccine in campaigns or by introduction into the routine immunization schedule. This paper describes the disease burden and vaccine implementation policy setting in the region, based on presentations and discussions at the second Asia Regional Meeting on Typhoid & TCV. Moving forward, typhoid control efforts must prioritize 1) working across health and finance ministries to finance vaccination programs, 2) strengthening surveillance to better understand disease burden, drug resistance trends, and vaccine impact, 3) developing improved diagnostic tests, 4) stewarding antimicrobial use to slow the spread of drug resistance, and 5) evaluating the durability of TCV protection.
期刊介绍:
Vaccine is unique in publishing the highest quality science across all disciplines relevant to the field of vaccinology - all original article submissions across basic and clinical research, vaccine manufacturing, history, public policy, behavioral science and ethics, social sciences, safety, and many other related areas are welcomed. The submission categories as given in the Guide for Authors indicate where we receive the most papers. Papers outside these major areas are also welcome and authors are encouraged to contact us with specific questions.